These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 26186193)

  • 1. Integrative Analyses of Human Reprogramming Reveal Dynamic Nature of Induced Pluripotency.
    Cacchiarelli D; Trapnell C; Ziller MJ; Soumillon M; Cesana M; Karnik R; Donaghey J; Smith ZD; Ratanasirintrawoot S; Zhang X; Ho Sui SJ; Wu Z; Akopian V; Gifford CA; Doench J; Rinn JL; Daley GQ; Meissner A; Lander ES; Mikkelsen TS
    Cell; 2015 Jul; 162(2):412-424. PubMed ID: 26186193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional and epigenetic mechanisms of cellular reprogramming to induced pluripotency.
    van den Hurk M; Kenis G; Bardy C; van den Hove DL; Gage FH; Steinbusch HW; Rutten BP
    Epigenomics; 2016 Aug; 8(8):1131-49. PubMed ID: 27419933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide characterization of the routes to pluripotency.
    Hussein SM; Puri MC; Tonge PD; Benevento M; Corso AJ; Clancy JL; Mosbergen R; Li M; Lee DS; Cloonan N; Wood DL; Munoz J; Middleton R; Korn O; Patel HR; White CA; Shin JY; Gauthier ME; Lê Cao KA; Kim JI; Mar JC; Shakiba N; Ritchie W; Rasko JE; Grimmond SM; Zandstra PW; Wells CA; Preiss T; Seo JS; Heck AJ; Rogers IM; Nagy A
    Nature; 2014 Dec; 516(7530):198-206. PubMed ID: 25503233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem Cell Surface Marker Expression Defines Late Stages of Reprogramming to Pluripotency in Human Fibroblasts.
    Pomeroy JE; Hough SR; Davidson KC; Quaas AM; Rees JA; Pera MF
    Stem Cells Transl Med; 2016 Jul; 5(7):870-82. PubMed ID: 27160704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique molecular events during reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) at naïve state.
    Wang Y; Zhao C; Hou Z; Yang Y; Bi Y; Wang H; Zhang Y; Gao S
    Elife; 2018 Jan; 7():. PubMed ID: 29381138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetics of reprogramming to induced pluripotency.
    Papp B; Plath K
    Cell; 2013 Mar; 152(6):1324-43. PubMed ID: 23498940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a small molecule that turns ON the pluripotency gene circuitry in human fibroblasts.
    Pandian GN; Sato S; Anandhakumar C; Taniguchi J; Takashima K; Syed J; Han L; Saha A; Bando T; Nagase H; Sugiyama H
    ACS Chem Biol; 2014 Dec; 9(12):2729-36. PubMed ID: 25366962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprogramming factor expression initiates widespread targeted chromatin remodeling.
    Koche RP; Smith ZD; Adli M; Gu H; Ku M; Gnirke A; Bernstein BE; Meissner A
    Cell Stem Cell; 2011 Jan; 8(1):96-105. PubMed ID: 21211784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the early and late responder genes during the generation of induced pluripotent stem cells from mouse fibroblasts.
    Park J; Kwon YW; Ham S; Hong CP; Seo S; Choe MK; Shin SI; Lee CS; Kim HS; Roh TY
    PLoS One; 2017; 12(2):e0171300. PubMed ID: 28152015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MacroH2A histone variants act as a barrier upon reprogramming towards pluripotency.
    Gaspar-Maia A; Qadeer ZA; Hasson D; Ratnakumar K; Leu NA; Leroy G; Liu S; Costanzi C; Valle-Garcia D; Schaniel C; Lemischka I; Garcia B; Pehrson JR; Bernstein E
    Nat Commun; 2013; 4():1565. PubMed ID: 23463008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early reprogramming regulators identified by prospective isolation and mass cytometry.
    Lujan E; Zunder ER; Ng YH; Goronzy IN; Nolan GP; Wernig M
    Nature; 2015 May; 521(7552):352-6. PubMed ID: 25830878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pluripotent state induction in mouse embryonic fibroblast using mRNAs of reprogramming factors.
    El-Sayed AK; Zhang Z; Zhang L; Liu Z; Abbott LC; Zhang Y; Li B
    Int J Mol Sci; 2014 Nov; 15(12):21840-64. PubMed ID: 25437916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of α-ketoglutarate-dependent proteins in pluripotency acquisition and maintenance.
    Tran KA; Dillingham CM; Sridharan R
    J Biol Chem; 2019 Apr; 294(14):5408-5419. PubMed ID: 30181211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X chromosome reactivation dynamics reveal stages of reprogramming to pluripotency.
    Pasque V; Tchieu J; Karnik R; Uyeda M; Sadhu Dimashkie A; Case D; Papp B; Bonora G; Patel S; Ho R; Schmidt R; McKee R; Sado T; Tada T; Meissner A; Plath K
    Cell; 2014 Dec; 159(7):1681-97. PubMed ID: 25525883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resetting epigenetic signatures to induce somatic cell reprogramming.
    Lluis F; Cosma MP
    Cell Mol Life Sci; 2013 Apr; 70(8):1413-24. PubMed ID: 22932957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concise review: Induced pluripotent stem cells versus embryonic stem cells: close enough or yet too far apart?
    Bilic J; Izpisua Belmonte JC
    Stem Cells; 2012 Jan; 30(1):33-41. PubMed ID: 22213481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromatin module inference on cellular trajectories identifies key transition points and poised epigenetic states in diverse developmental processes.
    Roy S; Sridharan R
    Genome Res; 2017 Jul; 27(7):1250-1262. PubMed ID: 28424352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of Brm and Baf170, Components of Chromatin Remodeling Complex, Facilitates Reprogramming of Somatic Cells.
    Jiang Z; Tang Y; Zhao X; Zhang M; Donovan DM; Tian XC
    Stem Cells Dev; 2015 Oct; 24(19):2328-36. PubMed ID: 26121422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives on somatic reprogramming: spotlighting epigenetic regulation and cellular heterogeneity.
    Chen J
    Curr Opin Genet Dev; 2020 Oct; 64():21-25. PubMed ID: 32599300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of pluripotency.
    Heffernan C; Liu J; Sumer H; Malaver-Ortega LF; Verma R; Carvalho E; Verma PJ
    Adv Exp Med Biol; 2013; 786():5-25. PubMed ID: 23696349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.